Log in to save to my catalogue

A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual ex...

A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual ex...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2711562208

A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group

About this item

Full title

A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group

Publisher

United States: BMJ Publishing Group Ltd

Journal title

International journal of gynecological cancer, 2022-09, Vol.32 (9), p.1205-1207

Language

English

Formats

Publication information

Publisher

United States: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Even if molecular biomarkers that are impacting clinical practice in gynecologic oncology are limited, our community is living in the precision medicine era where the number of patients undergoing tumor genomic profiling is increasing, as is the number of new drug approval for cancers with specific genetic alterations. In this complex scenario, mol...

Alternative Titles

Full title

A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2711562208

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2711562208

Other Identifiers

ISSN

1048-891X

E-ISSN

1525-1438

DOI

10.1136/ijgc-2022-003425

How to access this item